SEC Form D · filed February 13, 2014
Syndax Pharmaceuticals Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Dennis Podlesak · Waltham, MADirectorGeorge W. Sledge, Jr. M.D · Waltham, MADirectorIvor Royston · Waltham, MADirectorKim Kamdar, Ph.D · Waltham, MADirectorRichard P. Shea · Waltham, MADirectorArlene Morris · Waltham, MAExec · DirectorLuke Evnin, Ph.D · Waltham, MADirectorJohn Pallies · Waltham, MAExecFabrice Egros, Ph.D · Waltham, MADirectorRichard C. Temme · Woodland Hills, CADirectorLeslie P. Temme · Woodland Hills, CADirectorRonald P. Kirkpatrick · Ponte Verde, FLExecRichard G. Chyette · Livonia, MIDirectorRamkumar Mandalam · San Carlos, CADirectorLowell G. Sears · San Carlos, CADirectorStephen G. Greenberg · New York, NYExec · DirectorGisela G. Schwab · San Carlos, CADirectorAlbert Rabil, Iii · Boca Raton, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗